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Summary
Background.  —  In  STEMI  patients  treated  by  primary  PCI,  damage  of  the  microvascular  circu-
lation caused  by  distal  embolization  of  thrombotic  material  affects  the  quality  of  myocardialMyocardial reperfusion.  Important  controversies  remain  concerning  the  usefulness  of  the  manual  thrombec-
infarction;
Lethal  reperfusion
injuries;
Thrombosis
tomy to  improve  myocardial  perfusion.  The  aim  of  this  study  is  to  evaluate  the  impact  of  manual
thrombectomy  on  ST  resolution  as  a  surrogate  of  reperfusion  extent.
Methods.  —  Two  hundred  and  thirty-nine  consecutive  STEMI  patients  with  an  <12  hours  onset  of
symptoms,  were  enrolled  in  an  observational  registry.  Patients  were  divided  into  two  cohorts
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according  to  the  reperfusion  strategy:  manual  thrombectomy  before  primary  PCI  (n  =  102)  or
conventional-PCI  (n  =  137).  The  primary  endpoint  was  the  post  procedural  frequency  of  complete
(>70%) resolution  of  ST  segment  elevation.
Results.  —  A  complete  resolution  of  ST  segment  elevation  occurred  in  51.4%  of  patients  in  the
thrombectomy  group  and  in  35,6%  of  those  in  the  conventional-PCI  group  (P  =  0.018).  Thrombec-
tomy strategy  was  associated  with  a  lower  use  of  stents.  Multivariate  analysis  identiﬁed  manual
thrombectomy  (HR  =  2.08  IC  95%  (1.01—4.26);  P  =  0.046),  inferior  location  and  short  ischemic
delay (<180  min)  as  independent  predictors  of  ST  resolution.  The  cumulative  Kaplan-Meier  esti-
mate of  MACE  was  not  signiﬁcantly  different  between  the  two  groups  at  one,  three  years
follow-up.
Conclusion.  —  In  STEMI  patients,  manual  thrombectomy  improves  myocardial  reperfusion  as
assessed by  the  percentage  of  ST  segment  resolution  and  a  lower  use  of  stents.  However,  in  this
cohort of  limited  size,  this  strategy  did  not  translate  into  an  improved  cardiovascular  outcome
at one  year  follow-up.
©  2014  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Introduction.  —  Chez  les  patients  traités  par  angioplastie  primaire  pour  un  syndrome  coron-
aire aigu  avec  sus-décalage  du  segment  ST,  les  dommages  de  la  circulation  microvasculaire,
causés par  l’embolisation  distale  de  matériel  thrombotique,  affecte  la  qualité  de  la  reper-
fusion myocardique.  L’objectif  de  cette  étude  est  d’évaluer  l’impact  de  la  thromboaspiration
manuelle  sur  l’étendue  de  le  reperfusion  évaluée  par  la  résolution  du  segment  ST.
Méthodes.  —  Deux  cent  trente-neuf  patients  consécutifs  hospitalisés  pour  un  syndrome  coron-
aire aigu  avec  sus-décalage  du  segment  ST  ont  été  inclus  dans  un  registre  observationnel.  Ces
patients  ont  été  subdivisés  en  2  cohortes  selon  la  stratégie  de  reperfusion  usitée  :  thromboaspi-
ration manuelle  avant  angioplastie  primaire  (n  =  102)  ou  angioplastie  conventionelle  (n  =  137).
Le critère  de  jugement  principal  était  le  taux  de  résolution  complète  du  segment  ST  (déﬁnie
par une  RST  >  70  %)  post  procédural.
Résultats.  — Une  résolution  complète  du  segment  ST  a  été  observée  chez  51,4  %  des  patients
du groupe  Thromboaspiration  et  35,6  %  des  patients  du  groupe  angioplastie  conventionelle
(p =  0,018).  La  stratégie  de  thromboaspiration  était  associée  à  une  moindre  utilisation  de
stents. En  analyse  multivariée,  la  thromboaspiration  manuelle,  la  localisation  inférieure  de
l’infarctus  et  un  délai  court  de  reperfusion  (<  180  min)  sont  apparus  être  des  facteur  prédictifs
de résolution  complète  du  segment  ST.  L’analyse  de  Kaplan  Meier  portant  sur  les  évènements
cardio-vasculaires  adverses  ne  montrait  pas  de  différences  signiﬁcatives  entre  les  deux  groupes
pour un  suivi  de  1,3  ans.
Conclusion.  —  Chez  les  patients  se  présentant  pour  un  syndrome  coronaire  aigu  avec  sus-
décalage du  segment  ST,  la  thromboaspiration  manuelle  entraîne  une  amélioration  de  la
reperfusion  myocardique  attestée  par  une  fréquence  accrue  de  résolution  complète  du  seg-
ment ST  et  une  moindre  utilisation  de  stents.  Cependant,  dans  cette  cohorte  de  taille  limitée,
cette stratégie  ne  s’est  pas  accompagnée  d’une  amélioration  du  pronostic  cardiovasculaire  à  1
an.
© 2014  Elsevier  Masson  SAS.  Tous  droits  réservés.
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Developments  in  ischemic  myocardial  reperfusion  strate-
gies  have  considerably  improved  the  prognosis  of  patients
presenting  with  acute  ST-elevation  myocardial  infarction
(STEMI).  The  main  objective  of  reperfusion  strategies  in
STEMI  is  to  limit  infarct  size  and  improve  outcomes.  Primary
percutaneous  coronary  intervention  (primary  PCI)  is  the
reperfusion  reference  strategy  for  patients  presenting  with
STEMI  within  12  hours  of  symptom  onset  [1]. Nevertheless,
despite  restoration  of  epicardial  infarct  related  artery  ﬂow,
damage  of  the  microvascular  circulation  (microvascular
i
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Tbstruction)  occurs  in  a  sizeable  portion  of  cases  [2].
ngioplasty  can  be  complicated  by  spontaneous  or  proce-
ural  induced  distal  thrombotic  material  embolization  that
ay  alleviate  the  extent  of  myocardial  reperfusion.  Recent
ptical  coherence  tomography  data  have  nicely  demon-
trated  the  huge  amount  of  the  atherothrombotic  burden
hat  follows  stent  implantation,  with  a residual  throm-
us  being  detected  in  100%  of  cases.  None  surprisingly,
mportant  residual  thrombotic  burden  was  associated  with
ngiographic  no-ﬂow,  embolization  distal  occlusion  and  was
videnced  as  a  strong  predictor  of  ST  resolution  failure  [3].
he  extent  of  these  microvascular  injuries  is  associated  with
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orse  clinical  outcome  [4].  Preventing  embolization  theo-
etically  should  result  in  improved  reperfusion  success  as
easured  electrocardiographically  (increased  ST-segment
esolution  [STR]),  and  clinically  (enhanced  survival  free  from
ACE  and  heart  failure  events).  In  this  occurrence,  adjunc-
ive  devices  have  been  developed  to  reduce  the  thrombus
urden  and  to  minimize  the  risk  of  fragmentation  and
mbolization.  In  this  view,  manual  thrombus  aspiration  sys-
ems  appear  to  be  an  appealing  issue.  However,  evidences
upporting  a  systematic  use  of  manual  thrombectomy  before
rimary  PCI  are  still  debated  and  were  very  recently  chal-
enged  by  the  TASTE  trial  [5].  Moreover,  thrombus  aspiration
ay  not  be  a  risk-free  procedure.  Systemic  embolization  can
ccur,  and  in  a  recent  meta-analysis,  thrombus  aspiration
as  associated  with  a  trend  toward  an  increased  rate  of
troke  [6,7].  The  aim  of  this  study  was  to  assess  the  impact
f  manual  thrombus  aspiration  on  myocardial  reperfusion
hrough  ST-segment  resolution  assessment  and  new  Q  waves
eneration,  in  a  cohort  of  STEMI  patients  undergoing  primary
CI.
ethods
tudy population
he  data  analyzed  in  this  study  were  obtained  from  a
ingle-centre  cohort.  In  the  institutional  PCI  database,  we
dentiﬁed  consecutive  STEMI  patients  who  underwent  pri-
ary  PCI,  in  the  cardiology  centre  at  University  hospital  of
trasbourg,  France,  between  January  2009  and  September
011.  Patients  were  eligible  for  inclusion  if  they  presented
schemic  chest  pain  within  12  hours  of  symptom  onset,  and
 2  mm  ST  elevation  in  the  V1  to  V3  leads  or  1  mm  ST
levation  in  the  remaining  leads.  When  thrombus  aspira-
ion  was  performed,  only  STEMI  patients  treated  with  6F
spiration  catheter  (Export,  Medtronic,  Dancers,  MA,  USA)
ere  included  in  the  ﬁnal  study  cohort.  Exclusion  criteria
rom  the  analysis  were  ischemic  symptoms  for  >12  h,  pre-
ospital  cardiac  arrest,  an  ECG  showing  left  bundle  branch
lock  or  ventricular  pacing,  and  patients  already  included  in
nother  STEMI  research  protocol.  The  primary  PCI  procedure
nd  pharmacological  treatment  was  performed  according
o  the  standard  of  care  at  the  time  of  hospital  admis-
ion.  The  choice  to  perform  manual  thrombus  aspiration
as  at  the  discretion  of  the  operator.  Data  including  demo-
raphic,  clinical,  biological,  angiographic  and  procedural
haracteristics  were  extracted  from  the  PCI  and  the  ICU
atabases.  The  study  protocol  complied  with  the  tenets  of
he  Declaration  of  Helsinki.  Study  was  approved  by  our  Insti-
utional  Review  Board  and  all  participants  gave  informed
onsent.
lectrocardiography
nalysis  of  ST-segment  deviation  was  performed  (in  a
linded  fashion  according  to  use  or  not  of  manual  thrombec-
omy)  by  comparing  ECG  obtained  at  time  of  ﬁrst  medical
ontact  and  ECG  obtained  60  minutes  after  primary  PCI.
he  following  parameters  were  assessed  (measured  in  mil-
imeters):  sum  of  ST-segment  elevation  in  all  12  leads
cumulative  ST  elevation),  and  maximal  ST  elevation
T
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easured  in  the  lead  with  the  most  prominent  ST-segment
eviation.  A  complete  ST  segment  elevation  resolution
complete  STR)  was  deﬁned  when  the  regression  of  the  sum
f  ST-segment  elevation  before  and  after  PCI  reached  more
hen  70%.
linical outcomes
ollow  up  of  the  study  cohort  allowed  to  collect  the  follow-
ng  cardiac  events.
Major  adverse  cardiac  events  (MACE),  hospitalisation  for
cute  heart  failure.  MACE  was  deﬁned  as  a  composite  of
ll-cause  death,  recurrent  myocardial  infarction,  and  tar-
et  vessel  revascularization  (TVR).  Evidence  of  myocardial
einfarction  was  deﬁned  as  chest  pain  or  ECG  changes
ccompanied  by  a  reelevation  in  level  (>3  times  the  upper
imit  of  normal).  Target  vessel  revascularization  was  deﬁned
s  the  need  for  new  PCI  or  coronary  artery  bypass  graft  of
he  culprit  vessel  because  of  either  symptom  recurrence  or
 positive  ischemic  functional  test  at  follow-up.
nd points
he  primary  study  end  point  was  the  extent  of  myocardial
eperfusion  assessed  by  the  presence  or  not  of  complete  ST-
egment  elevation  resolution  (STR  >  70%),  60  minutes  after
PCI,  taking  into  account  the  sum  of  ST  elevation  in  all  12
eads  (cumulative  ST  elevation).
Secondary  endpoints  included  the  incidence  of  new
 waves  generation,  and  the  incidence  of  MACE  (death,
yocardial  infarction,  target  vessel  revascularisation),  of
ospitalisation  for  acute  heart  failure,  and  of  a  composite
nd  point  of  MACE  and  hospitalisation  for  acute  heart  fail-
re.
tatistical analysis
he  normal  distribution  of  the  studied  variables  was  tested
sing  the  D’agostino  and  Pearson  omnibus  normality  test.
ategorical  variables  were  expressed  as  count  and  per-
entages.  Continuous  variables  were  reported  as  mean  and
D  for  continuous,  or  as  medians  and  interquartile  ranges
ccording  to  their  distribution.  Categorical  variables  were
ompared  with  Chi2 test  or  Fisher’s  exact  test.  Continu-
us  variables  were  compared  with  the  use  of  Mann-Whitney
est.  To  determine  the  effect  of  thrombus  aspiration
n  the  primary  outcome,  logistic  regression  analysis  was
erformed.  Association  between  thrombus  aspiration  and
ccurrence  of  clinical  outcomes  was  assessed  by  Kaplan
eier  analysis  and  log  rank  test.  All  tests  were  2-sided.  A
 value  <  0.05  was  considered  signiﬁcant.  Calculations  were
erformed  using  SPSS  13.0  for  Windows  (SPSS  Inc.,  Chicago,
L,  USA).
esults
tudy population and baseline characteristicshe  ﬁnal  study  cohort  comprised  239  patients  who  were
reated  with  primary  PCI  and  who  did  meet  the  inclu-
ion  and  exclusion  criteria  between  January  1,  2009  and
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Table  1  Demographic  and  clinical  characteristics.
Conventional  PCI
(n  =  132)
Thrombectomy
(n  =  107)
P
Demographic  98  (74.2)  78  (72.9)  0.88
Male  sex,  n  (%)
Age,  year  59.8  ±  13.5  62.8  ±  15.3  0.11
Cardiovascular  risk  factor,  n  (%)
Current  smoking 76  (57.6) 70  (65.4)  0.23
Diabetes  mellitus 24  (18.2) 17  (15.9) 0.73
Hypertension  63(47.7)  43  (40.2) 0.29
Family  history  of  CAD 25  (18.9) 20  (18.7) 1
Hypercholesterolemia  58  (43.9)  42  (39.3)  0.51
BMI  >  30  kg/m2 36  (27.3)  17  (15.9)  0.042
Medical  history,  n  (%)
STEMI  8  (6.1)  5  (4.7)  0.77
NSTEMI  5  (3.8) 3 (2.8) 0.73
PCI  10  (7.6) 7  (6.5) 0.8
CABG  4  (3)  2  (1.9)  0.69
Stroke  5  (3.8)  0  (0)  0.06
Chronic  kidney  disease  6  (4.5)  5  (4.7)  1
Clinical
Anterior  STEMI  59  (44.7)  39  (36.4)  0.3
Systolic  blood  pressure,  mmHg  134.4  ±  23.9  132  ±  23.3  0.47
Diastolic  blood  pressure,  mmHg  78.3  ±  13.4  77.2  ±  14.3  0.55
Heart  Rate,  bpm  76.8  ±  15.7  75.2  ±  16  0.46
Killip  class
1  120  (90.9)  90  (84.1)  0.17
2  10  (7.6)  11  (10.3)
3  0  (0)  3  (2.8)
4  2  (1.5)  3  (2.8)
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PSeptember  30,  2011.  Of  these  patients,  137  patients  were
treated  with  primary  PCI  (conventional  PCI  group)  and  102
patients  underwent  adjunctive  manual  thrombus  aspiration
using  a  6F  export  aspiration  catheter  before  primary  PCI
(thrombectomy  group).  Baseline  demographic  and  clinical
characteristics  are  given  in  Table  1.  The  percentage  of  obese
patients  (BMI  >  30  kg/m2)  was  higher  in  the  conventional  PCI
group  (27.3%  vs.  15.9%,  P  =  0.042).  Other  demographic  and
clinical  characteristics  were  similar  in  the  two  groups  of
patients.
Angiographic and procedural data
Angiographic  and  procedural  characteristics  data  are  shown
respectively  in  Tables  2  and  3.  Ischemic  time  (time  delay
between  onset  of  symptoms  and  balloon  inﬂation)  did  not
signiﬁcantly  differ  between  the  two  groups.  Initial  TIMI  ﬂow
were  of  grade  0  to  1  more  frequently  in  the  thrombus  aspi-
ration  group  (95.3%  vs.  84.1%,  P  =  0.006).  The  percentage
of  direct  stenting  and  the  use  of  GPIIbIIIa  antagonists  was
equivalent  between  groups.  The  rate  of  stent  implantation
was  lower  in  the  thromboaspiration  group  (89.7  vs.  100%;
P  <  0.001).  In  addition,  the  diameter  of  the  stent  was  higher
in  the  thromboaspiration  group  (3.5  vs.  2.7  mm,  P  =  0.005).
Post  procedural  TIMI  2  to  3  ﬂow  grade  was  not  signiﬁcantly
different  between  the  two  groups  (conventional  PCI  group,
97.7%;  thrombus  aspiration  group,  95.7%;  P  =  0.11).
S
C
siological data
iological  data  are  given  in  Table  4.  Leukocytes
15,423/mm3 vs.12,410/mm3;  P  =  0.04)  and  platelets
ounts  (267.103/mm3 vs.  235.103/mm3;  P =  0.006)  were
igher  in  the  thrombectomy  group  as  was  peak  troponin  I
103.7  vs.  154.3  g/l;  P  <  0.001).
CG analysis and myocardial reperfusion
he  results  of  ECG  analysis  are  provided  in  Table  5. Post  pro-
edural  ST-segment  resolution  (expressed  as  a  percentage)
ould  be  assessed  in  all  patients.  In  the  full  cohort,  com-
lete  ST-segment  resolution  (cumulative  STR  >  70%)  occurred
n  42%  of  cases  after  primary  PCI.  Thrombectomy  before
tenting  resulted  in  improved  myocardial  reperfusion  docu-
ented  by  a  complete  STR  in  55  of  the  107  patients  (51.4%)
n  the  thrombus  aspiration  group  as  compared  with  47  of  the
32  pts  (35.6%)  in  the  conventional  PCI  group  (P  =  0.018).  In
ddition,  Q  waves  less  frequently  observed  in  the  thrombec-
omy  group  (46.7%  vs.  61,4%;  P  <  0.02).
atients characteristics according to
T-segment resolution
omparison  of  patients  with  and  without  complete  STR  is
hown  in  Table  6.  Complete  STR  was  associated  with  higher
676  N.  Messas  et  al.
Table  2  Angiographic  characteristics.
Conventional  PCI
(n  =  132)
Thrombectomy
(n =  107)
P
Infarct  related  artery,  n  (%)
Left  anterior  descending  artery  59  (44.8)  39  (36.4)  0.35
Left  circumﬂex  artery  30  (22.7)  28  (26.2)  0.54
Right  coronary  artery  39  (29.5)  39  (35.5)  0.79
Left  main  coronary  artery 4  (3) 2 (1.9) 0.69
No  of  diseased  vessel,  n  (%)
1  63  (47.7) 65  (60.7) 0.051
2  37  (28)  21  (19.7)  0.17
3  32  (24.2)  20  (18.7)  0.34
Initial  TIMI  ﬂow
0—1  111  (84.1)  102  (95.3)  0.006
2—3  21  (15.9)  5  (4.7)
Final  TIMI  ﬂow
0—1  3  (2.3)  7  (6.7)  0.11
2—3  129  (97.7)  98  (93.3)
Table  3  Procedural  characteristics.
Conventional  PCI
(n  =  132)
Thrombectomy
(n  =  107)
P
Total  ischemic  time,  h  4.4  ±  2.8  5.1  ±  3.2  0.12
Stent  implantation,  n  (%)  132  (100)  96  (89.7)  <0.001
Balloon  PCI  alone,  n  (%)  0  (0)  7  (6.5)  0.003
Direct  stenting,  n  (%)  68  (51.5)  57  (53.3)  0.79
Stent  diameter  (mm)  3  (2.7—3)  3  (3—3.5)  0.005
Stent  length  (mm)  20  (16—28)  22  (16.5—30.7)  0.18
No  of  stent  per  patient  (median  (IQR)  1  (1—2)  1  (1—2)  0.15
BMS,  n  (%) 107 (81.1)  81  (84.4)  0.59
DES,  n  (%) 25 (18.9) 15  (15.6)  0.59
GPIIbIIIa  antagonists,  n  (%) 94  (71.2)  84  (78.5)  0.23
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Dercentage  of  thrombectomy  procedure  (56.9%  vs.  34.3%,
 =  0.01).  Initial  TIMI  ﬂow  was  more  frequently  of  grade  0  to
 when  complete  STR  was  obtained  after  primary  PCI  (95.1%
s.  84.7%,  P  =  0.01).  Percentage  of  patients  with  short  reper-
usion  delay  (ischemic  time  <  3  h)  was  higher  when  complete
TR  occurred  after  primary  PCI.  Other  characteristics  did
ot  differ  signiﬁcantly  between  patients  with  and  without
omplete  STR.
nivariate and multivariate analysis of
rimary endpoint
nivariate  and  multivariate  analysis  performed  in  order  to
etermine  the  effect  of  thrombus  aspiration  on  complete
TR  occurrence  is  given  in  Table  7.
After  adjustment  for  confounding  factors  such  as
schemic  time,  initial  TIMI  ﬂow,  infarct  location,  smoking,
besity,  Diabetes,  troponin  I  peak,  maximal  ST  elevation,
nd  Killip  class,  Multivariate  analysis  identiﬁed  manual
hrombus  aspiration  as  an  independent  predictor  of  com-
lete  STR  (odds  ratio  =  1.82;  95%  CI,  1.01—3.17;  P  =  0.043).
ikewise,  early  reperfusion  deﬁned  by  ischemic  time  <  3  h
T
t
aodds  ratio  =  2.73;  95%  CI,  1.52—4.90;  P  =  0.001)  was  also
redictive  of  complete  STR.
linical outcomes
orbidity  and  mortality  data  are  presented  in  Table  8.  The
ean  follow-up  duration  was  1.3  ±  0.6  years.  Seven  patients
ied  in  the  full  cohort  (four  of  cardiac  and  one  of  non  cardiac
ause  in  the  conventional  PCI  group  and  two  of  cardiac  cause
n  the  thrombus  aspiration  group).  Rates  of  major  adverse
ardiac  events  (MACE)  and  hospitalization  for  acute  heart
ailure  were  similar  between  the  two  groups.  The  occur-
ence  of  composite  criteria  of  both  MACE  and  acute  heart
ailure  did  not  differ  signiﬁcantly  between  the  two  groups
ccording  to  the  Kaplan  Meier  curve  and  the  log  rank  test
valuation  (P  =  0.19)  shown  in  Fig.  1.
iscussionhe  main  ﬁnding  of  the  present  study  is  the  demonstration
hat  thrombus  aspiration  improved  myocardial  reperfusion
s  assessed  by  ST  segment  resolution  and  prevent  new  Q
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Table  4  Biological  characteristics.
Conventional  PCI
(n  =  132)
Thrombectomy
(n  =  107)
P
Glycemia  (g/dL)  1.3  (1.1—1.7)  1.3  (1.1—1.5)  0.44
HbA1  C  (%)  6  (5.6—6.5)  5.9  (5.7—6.4)  0.78
Serum  creatinine  (mol/L)  72.4  (59—85.1)  74  (63.3—86.4)  0.24
Peak  troponin  I  (g/L)  103.7  (92.4—157.7)  154.3  (125.3—198)  <0.001
BNP  (ng/L) 61  (21—198.5) 61  (18.7—138.5) 0.23
CRP  (mg/L) 13.7  (5.2—37.2) 9.4  (5.3—22.9) 0.18
Leukocyte  (/mm3) 12410 (9770—15400) 15423
(11770—17400)
0.004
Hemoglobin  (g/dL)  14.4  (13.3—15.4)  14.5  (13.3—15.4)  0.94
Platelets  (/mm3)  235.103
(199.103—290.103)
267.103
(223.103—326.103)
0.006
CT  (g/L)  1.8  (1.5—2.1)  1.8  (1.4  -2.2)  0.74
LDL  (g/L)  1.1  (0.8—1.4)  1.1  (1.1—1.5)  0.58
HDL  (g/L)  0.4  (0.3—0.5)  0.4  (0.4—0.5)  0.44
Triglyceride  (g/L)  1.1  (0.8—1.6)  1  (1—1.4)  0.10
Data are presented as median (interquartile range).
Table  5  ECG  analysis.
Conventional  PCI
(n  =  132)
Thrombectomy
(n =  107)
P
Before  PCI
Cumulative  ST  elevation  (mm)  5  (4—8)  8  (6—11))  <0.001
Maximal  ST  elevation  (mm)  2  (2—3)  2  (2—3)  0.002
After  PCI
Cumulative  ST  elevation  (mm)  3  (1—5)  2  (0—4)  0.26
Maximal  ST  elevation  (mm)  1  (1—2)  1  (0—2)  0.25
Q  waves  81  (61.4)  50  (46.7)  0.02
Percentage  of  ST  segment  resolution  (%)  44.9  (20—81.3)  70.5  (50—100)  <0.001
Cumulative  complete  STR  (>70%),  n  (%) 47  (35
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aves  generation.  In  addition,  such  strategy  is  associated
ith  a lower  use  of  stent.  However,  in  our  hand,  thrombus
spiration  did  not  translate  into  an  improved  cardiovascular
utcome  at  1.3-year  follow-up.
hrombus aspiration and myocardial
eperfusion
n  our  study,  adjunctive  manual  thrombus  aspiration  before
rimary  PCI  of  STEMI  patients  improved  myocardial  reper-
usion  as  assessed  by  increased  frequency  of  post  procedural
omplete  ST  segment  resolution  (STR  >  70%,  51.4%  vs.  35.6%,
 =  0.018).  After  adjusting  for  potential  confounding  factors,
hrombectomy  appeared  to  be  an  independent  predicting
actor  of  better  myocardial  reperfusion  (odds  ratio  =  1.73;
5%  CI,  1.02—2.98;  P  =  0.045).  The  improvement  of  myocar-
ial  perfusion  is  also  underlined  by  a  lower  rate  of  Q
aves.  In  this  non-randomized  trial,  the  higher  peak  of  tro-
onin  observed  in  the  thrombus  aspiration  group  is  difﬁcult
o  interpret.  Possible  explanation  relies  on  an  acceler-
ted  washout  as  a  result  of  improved  perfusion.  Given
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Table  6  Comparison  of  patients  with  and  without  complete  STR.
Complete  STR
(n =  102)
No complete  STR
(n  =  137)
P
Demographic  data
Male  sex,  n(%)  78  (76.5)  98  (71.5)  0.45
Age,  year 59.9  ±  13.9 62.5  ±  14.6  0.16
Cardiovascular  risk  factor,  n  (%)
Current  smoking 68  (66.7) 78  (56.9) 0.14
Diabetes  mellitus  18  (17.6)  23  (16.8)  0.86
Hypertension  44  (43.1)  62  (45.3)  0.79
Family  history  of  CAD  20  (19.6)  25  (18.2)  0.86
Hypercholesterolemia  45  (44.1)  55  (40.1)  0.59
BMI  >  30  kg/m2 24  (23.5)  29  (21.2)  0.75
Medical  history,  n  (%)
STEMI  6  (5.9)  7  (5.1)  0.78
Stroke  0  (0)  5  (3.6)  0.07
Chronic  kidney  disease  3  (2.9)  8  (5.8)  0.36
Angiographic  and  procedural  data,  n  (%)
Non-anterior  STEMI  15  (14.7)  16  (11.7)  0.56
Initial  TIMI  ﬂow  0-1 97  (95.1)  116(84.7)  0.01
Ischemic  time  <  3  h  (symptoms  to  balloon) 58  (56.9) 47  (34.3)  0.001
Thrombectomy  55  (53.9)  52  (38)  0.01
GPIIbIIIa  antagonists 79  (77.5) 99  (72.3)  0.37
DES  15  (16)  25  (18.7)  0.72
Direct  stenting 56  (54.9) 69  (50.4)  0.51
Biological  data,  median  (interquartile  range)
Troponin  I  peak(g/L) 76 (38—159) 68  (33—151) 0.77
CRP  (mg/L) 9  (5—22) 14  (5—31) 0.25
BNP  (ng/L) 40  (16—92) 82  (25—231)  0.002
ECG  analysis,  median  (Interquartile  range)
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he  higher  rate  of  preprocedural  total  coronary  occlusion
TIMI  0)  observed  in  the  thrombus  aspiration  group,  we
ould  not  exclude  that  initial  differences  in  the  extent
f  jeopardized  myocardium  may  constitute  an  alternate
xplanation.  Because  high  thrombotic  burden  is  a major
eterminant  of  ST  segment  resolution  failure,  the  reduction
f  the  thrombotic  loads  by  manual  thrombectomy  appears
o  be  an  intuitive  appealing  approach  to  reduce  thrombus
a
r
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Table  7  Univariate  and  Multivariate  analysis  for  identiﬁcation
Factors  associated  with  complete  ST-segment  resolution  (STR  >
Univariate  and  multivariate  analysis
Characteristics  Univariate  OR  (
Thrombectomy  1.91  (1.13—3.21
Ischemic  time  <  3  h  (symptoms  to  balloon)  2.03  (1.13—3.67
Initial  TIMI  ﬂow  0-1  0.28  (0.10—0.78
Non-anterior  infarct  location  1.54  (1.07—2.21
Current  smoking  1.51  (0.88—2.57
BMI  >  30  kg/m2 1.14  (0.62—2.11
Troponin  I  peak  0.79  (0.0.78—1.
Maximal  ST  elevation 1.02  (0.95—1.09
Diabetes  mellitus  1.06  (0.53—2.09
Killip  class  >  2  0.80  (0.18—3.42)  2  (2—3)  0.64
ragmentation  and  subsequent  microembolization.  Our
esults  are  in  line  with  previous  of  single-centre  prospec-
ive  randomized  studies  addressing  the  impact  of  thrombus
spiration  in  the  acute  phase  of  STEMI  on  myocardial  reper-
usion.  In  the  TAPAS  trial,  thrombus  aspiration  with  a  6F
spiration  catheter  (Export,  Medtronic,  USA)  improved  the
ate  of  myocardial  reperfusion  as  judged  by  myocardial
lush  grade  (MBG)  or  ST  segment  resolution  [8]. Likewise,
 of  Predictors  of  complete  STR.
 70%)
95%  CI)  P  Multivariate  OR  (95%  CI)  P
)  0.01  1.82  (1.02—3.27)  0.043
)  0.01  2.73  (1.52—4.90)  0.001
)  0.01  0.66  (0.43—1.01)  0.056
)  0.01  1.70  (0.74—3.90)  0.20
)  0.10  1.21  (0.67—2.16)  0.51
)  0.16  1.21(0.61—2.38)  0.57
01)  0.16  0.99  (0.99—1.00)  0.29
)  0.56
)  0.86
)  0.76
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Table  8  Incidence  of  Major  cardiac  events  (MACE)  and  Acute  heart  failure.
Conventional  PCI
(n  =  132)
Thrombectomy
(n =  107)
Death,  n  (%)  5  (4.1)  2  (2)
Cardiac  death,  n  (%) 4 (3.3) 2  (2)
Myocardial  reinfarction,  n  (%) 3  (2.5) 1  (1)
TVR,  n  (%) 11  (9.1) 8  (8.2)
MACE,  n  (%)  19  (15.7)  12  (12.2)
Admission  for  acute  Heart  Failure,  n  (%)  7  (5.8)  2  (2)
MACE  +  AHF  26  (19.6)  14  (13)
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Sin  the  EXPIRA  trial,  thrombectomy  improved  the  myocardial
reperfusion  as  assessed  by  a  higher  rate  of  ST  segment  reso-
lution  [9].  In  the  latter  trial,  the  improvement  of  myocardial
perfusion  was  associated  with  a  reduction  of  infarct  size
as  assessed  by  MRI  analysis.  Accordingly,  two  recent  meta-
analyses  have  suggested  that  manual  thrombus  aspiration
strategy  might  improve  the  quality  of  myocardial  perfusion
[10,11].  This  promising  paradigm  ‘‘reduction  of  throm-
bus  burden  as  a  tool  to  avoid  micro-embolization’’  was
however  challenged  by  data  obtained  in  larger  cohort  of
multi-centre  trials.  For  instance,  in  the  INFUSE-AMI  study
that  have  explored  four  strategies  (abciximab,  thrombus
aspiration,  thrombus  aspiration  +  abciximab,  and  no  abcix-
imab  +  no  thromboaspiration),  the  infarct  size  endpoint
assessed  at  30  days  by  cardiac  magnetic  resonance  imaging
(MRI)  was  nearly  identical  in  the  aspiration  and  control  arms
as  were  TIMI  ﬂow,  MBG,  and  STR  [12].  Although  the  extent  of
ST  resolution  was  not  investigate  in  the  TASTE  trial,  cardiac
enzyme  release  as  a  surrogate  marker  of  infarct  size  was  not
signiﬁcantly  reduced  in  the  thrombus  aspiration  group  [5].
Other predictors of ST resolution
Besides  the  reduction  of  the  thrombus  load  using  man-
ual  thrombectomy,  short  reperfusion  delay  represent  other
predictors  of  ST  resolution.  In  univariate  analysis,  a  short
delay  is  associated  with  better  reperfusion  evidenced  by
a  higher  frequency  of  post-procedure  complete  ST  reso-
lution  (STR  >  70%,  OR  =  0.86,  95%  CI  0.78—0.95;  P  =  0.001)
and  becomes  an  independent  predicting  factor  of  complete
STR  even  after  adjustment  for  confounding  factors.  Taking
into  account  the  temporal  evolution  of  myonecrosis  [13],
these  data  underlined  the  fact  that  early  reperfusion  is
probably  an  ideal  condition  to  demonstrate  myocardial  sal-
vage  which  is  also  consistent  with  histopathology  ﬁndings  on
thromboaspiration  products.  Whilst  the  thrombus  is  mainly
of  platelet  origin  within  the  two  ﬁrst  hours,  older  throm-
bus  are  characterized  by  a  complex  network  of  ﬁbrin  and
erythrocytes  more  likely  resistant  to  the  ﬁbrin-degrading
proteolytic  enzyme  and  probably  less  accessible  to  ade-
quate  thromboaspiration  [14].  In  the  literature,  the  impact
of  initial  TIMI  ﬂow  on  ST  resolution  remains  controversial.
According  to  Erden  et  al.,  the  ST  resolution  was  lower  in
patients  with  spontaneous  coronary  reperfusion  prior  PCI
[15].  Conversely,  other  work  has  suggested  that  TIMI  ﬂow
grade  2  or  less  before  pPCI  could  be  an  independent  predic-
tor  of  impaired  ST  resolution  [16].
t
t
•anual thrombectomy and clinical outcomes
n  spite  of  improved  ST  resolution,  no  differences  in  MACE
nd  heart  failure  could  be  evidenced  at  1.3  years  follow  up.
he  notion  that  manual  thrombectomy  has  a  real  impact
n  cardiovascular  outcome  was  recently  challenged  by  the
ASTE  trial.  Previous  observations  from  the  TAPAS  trial  have
uggested  that  thrombus  aspiration  resulted  in  a  trend
oward  improved  30-day  survival,  which  became  signiﬁcant
y  one  year  [17].  Surprisingly,  this  improvement  on  survival
as  observed  in  spite  of  any  sizeable  reduction  of  infarct
ize  measured  by  cardiac  enzyme  release.  Therefore,  the
athophysiological  basis  associating  thrombus  aspiration  and
eduction  of  cardiac  mortality  remained  unclear.  Recent
eta-analysis  have  reported  conﬂicting  ﬁndings,  showing
ither  a  reduction  of  30-days  mortality  rate,  mainly  draw
y  the  TAPAS  trial  [10,18]  or  a  lack  of  efﬁciency  [11].  In
he  multicenter  INFUSE  MI  trial,  no  signiﬁcant  reduction  of
ortality  could  be  established  in  patients  treated  by  throm-
us  aspiration.  Likewise,  the  30  days  outcome  of  patients
nrolled  in  the  large  TASTE  trial  has  been  recently  pub-
ished.  In  this  nation  wide  large  multicenter  trial  enrolling
244  patients,  thrombus  aspiration  did  not  improve  the  30
ays  rate  of  death,  rehospitalisation  for  heart  failure  or
troke.  Stent  thrombosis  or  rehospitalisation  for  myocardial
nfarction  tended  to  be  lower  in  the  thrombus  aspiration
roup  [5]. In  our  study,  in  spite  of  the  improvement  of  ST-
egment  resolution  observed  in  the  thrombectomy  group,
T  resolution  failure  was  detected  in  48%.  The  question
hether  unsuccessful  microcirculatory  perfusion  is  due  to
icro-embolization  or  results  from  lethal  reperfusion  injury
eserves  further  investigation.
imitations
he  present  work  is  monocentric  and  has  the  inherent  limi-
ations  of  any  small  non-randomized  series.  Blush  score  and
IMI  frame  count,  other  markers  of  myocardial  perfusion
ere  not  assessed.  Infarct  size  and  no  reﬂow  phenomenon
ere  not  analyzed  by  MRI.
The  thrombotic  material  was  not  quantiﬁed.  However,  in
TEMI  patients  the  evaluation  of  the  thrombotic  burden  by
he  measurement  of  the  thrombotic  material  retrieved  by
hrombectomy  remains  difﬁcult  to  assess:
large  thrombus  could  not  be  aspirate  by  the  current  avail-
able  device;
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even  in  case  of  thrombectomy,  residual  thrombotic  mate-
rials  could  be  detected  within  the  implanted  stent  by  OCT
in  almost  100%  of  the  cases  [3].
Other  limitations  are  represented  by  the  absence  of  ECG
ndependent  reviewing  and  the  absence  of  accurate  col-
aterally  evaluation.  Finally,  given  the  limited  size  of  our
opulation,  and  the  low  number  of  adverse  events  recorded
uring  follow  up,  the  present  study  was  not  powered  to  draw
eﬁnite  conclusion  on  the  impact  of  thrombus  aspiration
trategy  on  clinically  relevant  hard  points.
onclusion
n  STEMI  patients  treated  by  primary  PCI,  manual  thrombec-
omy  results  in  improved  myocardial  reperfusion  as  assessed
y  ST  segment  resolution  and  a  lower  use  of  stents.  How-
ver,  in  this  cohort  of  limited  size,  this  strategy  did  not
ranslate  into  an  improved  cardiovascular  outcome  at  1-year
ollow-up.
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